© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Search results for

Tip: Use operators exact match "", AND, OR to customise your search. You can use them separately or you can combine them to find specific content.
There are 373,284 results that match your search.373,284 results
  • The EuroMTN market enjoyed a period of rude health in 2003 and borrowers, investors and dealers profited across the board.
  • The popularity of the EuroCP market continued to grow in 2003 and activity in the market reflected this increased appetite.
  • Having taken the plaudits from borrowers for its performance in 2003, Citigroup also won the lion's share of acclaim in EuroWeek's first ever EuroMTN peers' poll.
  • Last year provided more than its fair share of excitement for the lads from Leak, but as far as our star award was concerned, there was really only one winner wasn't there? One market maker who's name was permanently up in lights in 2003.
  • The rise of the European corporate bond market over the past decade has left many retail investors on the sidelines as transactions have magnified in size and deal structures have become increasingly complex. However, investment banks and borrowers have realised that there are benefits to making life easier for smaller investors. Duncan Kerr reports.
  • Top
  • ABN AMRO expects to close its first synthetic collateralized debt obligation in China in the coming days.
  • Crédit Agricole Indosuez and Crédit Lyonnais are preparing to launch a pair of asset-backed synthetic collateralized debt obligations, in the run-up to the integration of the firms next month.
  • UBS has hired Dariush Mirfendereski, head of inflation derivatives trading at Barclays Capital in London.
  • The bank debt for Mayflower Corp. came under intense pressure this week as the company announced that it was insolvent and was appointing administrators.
  • Metaldyne Corp. is in talks with its lenders to provide waivers of late financial reporting and to secure continued access to the $200 million revolver portion of its bank debt.
  • The bank debt levels for aaiPharma?s $156 million term loan ?B? have been sliding down over the last couple of weeks as the company comes under scrutiny for unusual pharmaceutical sales in the second half of 2003.